Literature DB >> 15805708

Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis.

Yoshiko Kadokawa1, Katsuhisa Omagari, Kazuo Ohba, Satoko Kitamura, Hiroshi Ohara, Fuminao Takeshima, Yohei Mizuta, Atsushi Nanashima, Hiroyuki Yamaguchi, Shigeru Kohno.   

Abstract

The true incidence of hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) remains undetermined due to limited epidemiological studies and some conflicting results. Some studies indicated that in PBC, male gender, cirrhosis, hepatitis C virus (HCV) superinfection, and history of blood transfusion are associated with the development of HCC, and the occurrence of HCC in the early stage of PBC is rare. We present herein a 75-year-old male patient with stage I PBC who developed oropharyngeal squamous cell carcinoma, followed by HCC and duodenal adenocarcinoma without hepatitis B or C virus infection. While it could be argued that the concurrence of HCC and stage I-PBC in our patient was coincidental, patients with early stage PBC should be strictly followed up as cirrhotic patients with PBC by monitoring the serum concentration of tumor markers for HCC and appropriate imaging methods.

Entities:  

Mesh:

Year:  2005        PMID: 15805708     DOI: 10.2169/internalmedicine.44.207

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Embolization of cyanoacrylate glue in systemic circulation in a case of hepatocellular carcinoma: an autopsy report.

Authors:  Kirti Gupta; Rakesh K Vasishta; Usha Dutta; Rakesh K Kochhar; Kartar Singh
Journal:  Diagn Pathol       Date:  2009-12-09       Impact factor: 2.644

2.  Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma.

Authors:  Ryuta Ide; Akihiko Oshita; Takashi Nishisaka; Hideki Nakahara; Shiomi Aimitsu; Toshiyuki Itamoto
Journal:  World J Hepatol       Date:  2017-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.